In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...

In this report, we summarize the findings of 10 phase 3 and 4 clinical studies evaluating coadministration of the quadrivalent meningococcal conjugate vaccine ... to the diphtheria toxoid 1 ...

As quadrivalent meningococcal conjugate vaccines offer the broadest, most durable and most effective protection, they are the preferred option over polysaccharide vaccines. However, conjugate ...